QTREX Quantum Ltd. (QTEX) Stock

About QTREX Quantum Ltd.

QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.

QTREX Quantum Ltd. is led by CEO Dagi Shahar Ben-Noon, employs 34 people, headquartered in IL, publicly traded since 2021.

QTREX Quantum Ltd. (QTEX) stock trades at $1.06 with a market capitalization of $46.19M. The stock is valued at a price-to-earnings (P/E) ratio of -1.98, price-to-book of 13.75, price-to-sales of 172.25. Over the past 52 weeks the stock has ranged between $0.28 and $3.85, and currently trades 72.5% below its 52-week high.

On profitability, QTREX Quantum Ltd. generates a return on equity (ROE) of -397.89%, an operating margin of -4713.84%, a net profit margin of 0.00%.

Official website: www.q-trex.com